Drug industry to perceive production necessity for smaller package sizes.

Most of drug companies are revoicing their production necessity for smaller package size drugs realizing the fact that the drug dividing works at wholesalers would never make any sufficient relief for their cost-bearing burdens.

The wholesaler community claimed that they should absorb the dividing costs under their current limited 5% distribution margin, which was supposed to take over by th...